Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985;85(3):333-9.
doi: 10.1007/BF00428198.

Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval

Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval

R Castro et al. Psychopharmacology (Berl). 1985.

Abstract

Administration of drugs that reduce the influence of dopamine at its receptor site can lead to postsynaptic supersensitivity, whereas treatment with dopamine (DA) agonists can cause postsynaptic subsensitivity. Both unaltered and enhanced postsynaptic responses to DA have been shown after pretreatment with DA agonists. In the present manuscript pretreatment with apomorphine, a dopaminergic agonist, is shown to induce either increased or reduced locomotor activity. When a drug-free period between successive injections was allowed, apomorphine induced an enhanced locomotor response, whereas a reduced response occurred when each dose was injected before the previous apomorphine dose had been completely metabolized. Pretreatment with both high (1 and 3 mg/kg) and low (0.05 mg/kg) apomorphine doses enhanced the response. Apomorphine treatment that caused enhanced locomotor responses did not modify the stereotypy response to the drug. Similar enhanced or reduced response were found in rats with partial lesions of the nigrostriatal system. These altered responses to DA agonists may have important clinical consequences. The present data also suggest the existence of a different DA systems for locomotor and stereotypy actions of dopaminergic agonists.

PubMed Disclaimer

References

    1. Neurology. 1980 Jul;30(7 Pt 1):785-8 - PubMed
    1. J Neural Transm. 1981;51(1-2):97-106 - PubMed
    1. Eur J Pharmacol. 1982 Jun 16;81(1):1-9 - PubMed
    1. Brain Res. 1982 Dec 16;253(1-2):231-41 - PubMed
    1. Psychopharmacology (Berl). 1980;68(1):77-83 - PubMed

LinkOut - more resources